Silence Therapeutics SLN
NASDAQ SLN
$19.67 +0.06 (+0.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Payables (2018 - 2023)

Updated

Silence Therapeutics' Payables was $15.43 million in the quarter ended Dec 31, 2023, up 4.1% from $14.82 million a year earlier.

Analysis

Silence Therapeutics (SLN) Payables (2018 - 2023) Analysis & Trends

From the quarter ended Dec 31, 2018 onward, Silence Therapeutics has reported Payables for 6 quarters.

  • Payables shows a five-year compound annual growth rate of 24.7% (years ended Dec 2018 to Dec 2023).
  • In earlier years, Payables was $15.63 million in the year ended Dec 31, 2022 (+5.4%), $14.84 million in the year ended Dec 31, 2021 (+41.0%), $10.52 million in the year ended Dec 31, 2020 (+19.6%) and $8.79 million in the year ended Dec 31, 2019 (+71.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.92 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.30 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 7.03 Bn
10 Silence Therapeutics 927.96 Mn 855.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 15.83 Mn
Dec 31, 2022 15.23 Mn
Dec 31, 2021 14.56 Mn
Dec 31, 2020 11.17 Mn
Dec 31, 2019 9.03 Mn
Dec 31, 2018 4.86 Mn
API Access

Silence Therapeutics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=SLN&period=max&api_key=YOUR_API_KEY